CERTIFIED METHADONE ADVOCATE (CMA)-1

The Advocacy Training Session

The training for certification includes a
variety of topics to give advocates a well-grounded understanding of
methadone treatment, research, regulations and laws that protect
methadone patients and programs.

  1. Addiction and Methadone The
    biological constructs of addiction will be explained in a way that
    can be understood by lay people (i.e. opiate receptors, Endorphins)
    Methadone dose and what is considered an adequate dose and why it is
    important and what methadone does to make you feel normal.
  2. Regulations and Accreditation The new federal regulations will be explained:  What
    they are and how they relate to the state regulations? Accreditation
    and what an accreditation survey is, how it is done, and how
    advocates can be involved.
  3. The Different Faces of Advocacy Advocates from around the country will explain what they do to
    advance the goals of methadone advocacy. This session will also
    explain the different types of advocacy that advocates are involved
    in.
  4. How to End Methadone Stigma The history of
    methadone stigma will be presented and how it has impacted methadone
    treatment and the recipients of it. A plan for advocates to work on
    for ending it will be revealed.
  5. Advocate Certification What is certification and how it
    will professionalize those committed to methadone advocacy.  The Advocates Code of Ethics, the Goals of Methadone
    Advocacy, and Advocate Certification.

Similar Posts

  • Month: May 2022

    Admin 08/27/2022

    Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award! May 1, 2022 Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive Director of Man Alive and later served as Vice President…

  • |

    DRAFT

    Admin 06/23/2022

    Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office Draft approved for distribution July 2001 THE FEDERATION OF STATE MEDICAL BOARDS OF THE UNITED STATES, INC. Introduction On October 17, 2000, “The Children’s Health Act of 2000” (HR 4365) was signed into federal law. Section 3502 of that Act sets forth the “Drug…

  • Basic Pharmacology: How Methadone Works? Part I Introduction by Joycelyn Woods

    Admin 04/06/2022

    Education Series Number 5.1 February 2001 (Revised) Joycelyn Woods has a graduate degree in neuroscience and psychopharmacology. She has published in neuroscience journals and is recognized internationally for her methadone advocacy work. She is a recipient of the “Richard Lane Methadone Advocacy Award.” The Lack of Education Ignorance about methadone abounds (Zweben and Sorensen, 1988)….

  • |

    Basic Information About Buprenorphine

    Admin 04/20/2023

    Basic Information About DATA On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of schedule III, IV or V opioid treatment drugs that are approved by the FDA for maintenance or detoxification treatment. Summary of Title XXXV NIDA/SAMHSA Announcement & Press Release NIDA Research and…

  • Reception

    Admin 08/15/2021

    Welcome to The President’s Office and to the National Alliance for Medication Assisted Recovery or NAMA Recovery. NAMA Recovery has gone through some significant changes in the past few years. We are proud of the MARS Project the first project of its kind that provides recovery services to patients receiving Medication Assisted Treatment (MAT). As…

  • MOVING FORWARD

    Admin 10/25/2021

    Invitational Conference on Drug User Activism International Drug User Day 2003, October 31st/November 1st Copenhagen, Denmark The Danish Drug Users Union – BrugerForeningen and the Dutch National Interest Group of Drug Users – Landelijk Steunpunt Druggebruikers sponsor “Moving Forward” a meeting on drug user activism. The gathering was to mark both the International Drug User…